Psoriasis: Clinical Trials

19 trials for Psoriasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 unknown. 19 Phase 2, 3 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 219Unknown 19
Phase 13Unknown 3
Phase 33Unknown 3

Follow Psoriasis: new trials by email Literature Review of Psoriasis trials Research Report on Psoriasis

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Ixekizumab in Patients with Refractory Guttate Psoriasis
Ixekizumab - Guttate Psoriasis
Phase 2 / Phase 3UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine502025-05-012025-02-10
Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis
HB0034 - Generalized Pustular Psoriasis
Phase 2 / Phase 3UnknownShanghai Huaota Biopharmaceutical Co., Ltd.332024-09-022025-02-14
Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
HS-10374, HS-10374-matched placebo tablets, Tofacitinib 5Mg Tab,Oral - Psoriatic Arthritis
Phase 2UnknownHansoh BioMedical R&D Company1602024-02-262024-07-18
A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
HS-10374 tablets 1mg, HS-10374 tablets 5mg, HS-10374-matched placebo tablets - Psoriasis
Phase 2UnknownHansoh BioMedical R&D Company1202023-09-282023-12-06
A Study of QY101 Ointment in Subjects With Plaque Psoriasis
QY101Placebo/QY101 ointment - Psoriasis
Phase 2UnknownE-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.1602023-05-172023-12-19
Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis
Umbilical cord mesenchymal stem cells - Mesenchymal Stromal Cells, Psoriasis
Phase 1 / Phase 2UnknownGuangdong Provincial Hospital of Traditional Chinese Medicine52021-08-312021-02-09
A Phase 2 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection, Placebo - Psoriasis
Phase 2UnknownSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.1392021-04-012022-11-08
Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis
PSORI-CM01 formula, Gu Ben Hua Yu formula, adipose-derived multipotent mesenchymal stem cells - Traditional Chinese Medicine, Drug Effect
Phase 1 / Phase 2UnknownGuangdong Provincial Hospital of Traditional Chinese Medicine162021-03-172023-08-24
Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement
Tofacitinib 5 MG Oral Tablet [Xeljanz], Placebo oral tablet - Psoriatic Arthritis, Spondylitis
Phase 2UnknownCharite University, Berlin, Germany802020-08-042022-07-26
Psoriasis、Indigo Naturalis、Chinese Medicine Medicated Bath
paper mulberry leaf, Triamcinolone (Encort-A) 0.1%15g/Tube - Psoriasis
Phase 2UnknownChina Medical University Hospital302019-10-052019-10-16
Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial
Turmeric Extract, Turmeric Extract in Olive oil, Petrolatum - Psoriasis
Phase 2 / Phase 3UnknownZagazig University502019-09-012019-08-28
Chinese Herbal Medicine for Psoriasis Vulgaris: a Real World Study
Oral Chinese Herbal Medicine of Clearing heat and Cooling blood therapy, Oral Chinese Herbal Medicine according with syndrome differentiation therapy, Oral Chinese Herbal Medicine of Promoting blood circulation and Removing blood stasis therapy - Psoriasis
Phase 2UnknownShanghai Yueyang Integrated Medicine Hospital20002019-06-012019-05-08
Topical Psoralen Ultraviolet Light A Versus Narrow Band Ultraviolet Light B Treatment for Recalcitrant Dermatoses of the Hand
Phototherapy - Vitiligo
Phase 2UnknownUniversity of British Columbia302013-02-012015-07-02
A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118
IDP-118 Low Strength, IDP-118 High Strength - Plaque Psoriasis
Phase 1 / Phase 2UnknownDow Pharmaceutical Sciences602012-06-012013-04-25
Vaccination Against Influenza H1N1 in Rheumatic Diseases
Focetria (Monovalent MF59-Adjuvanted vaccine) - Influenza, Rheumatic Diseases
Phase 2UnknownTel-Aviv Sourasky Medical Center4002009-11-012009-11-03
Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis
IP10.C8 - Psoriasis
Phase 2UnknownImmune Technologies & Medicine GmbH242009-01-012009-01-19
99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity
99mTc-anti-TNF-alpha Scintigraphy - Psoriatic Arthritis, Arthritis
Phase 2UnknownUniversidade Federal do Rio de Janeiro502009-01-012016-05-27
Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail Psoriasis
Methotrexate - Fingernail Psoriasis
Phase 2UnknownMediQuest Therapeutics832007-10-012009-02-10
CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.
Cyclosporine A versus mycophenolate mofetil for psoriasis - Psoriasis
Phase 2UnknownUniversity Hospital Muenster502000-05-012006-10-05

Narrower conditions

Arthritis, Psoriatic (4)  ·  Arthritis (1)  ·  Arthritis, Rheumatoid (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Eczema (1)  ·  Guttate Psoriasis (1)  ·  Inflammation (1)  ·  Influenza, Human (1)  ·  Rheumatic Diseases (1)  ·  Sacroiliitis (1)  ·  Spondylitis (1)  ·  Vitiligo (1)

Broader conditions

Skin Diseases (19)  ·  Skin Diseases, Papulosquamous (19)  ·  Skin and Connective Tissue Diseases (19)  ·  Bone Diseases (4)  ·  Joint Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Spinal Diseases (4)  ·  Spondylarthritis (4)  ·  Spondylarthropathies (4)  ·  Arthritis (3)  ·  Spondylitis (3)  ·  Connective Tissue Diseases (2)  ·  Infections (2)  ·  Autoimmune Diseases (1)

Interventions

tofacitinib (2)  ·  Betamethasone (1)  ·  Methotrexate (1)  ·  Olive Oil (1)  ·  Petrolatum (1)  ·  Phototherapy (1)  ·  Tablets (1)  ·  Triamcinolone (1)  ·  calcipotriene (1)  ·  focetria (1)  ·  ixekizumab (1)  ·  turmeric extract (1)

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine (2)  ·  Hansoh BioMedical R&D Company (2)  ·  Charite University, Berlin, Germany (1)  ·  China Medical University Hospital (1)  ·  Dow Pharmaceutical Sciences (1)  ·  E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. (1)  ·  Immune Technologies & Medicine GmbH (1)  ·  MediQuest Therapeutics (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Shanghai Huaota Biopharmaceutical Co., Ltd. (1)  ·  Shanghai Yueyang Integrated Medicine Hospital (1)  ·  Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  Universidade Federal do Rio de Janeiro (1)  ·  University Hospital Muenster (1)

Countries

China (8)  ·  Germany (2)  ·  Brazil (1)  ·  Canada (1)  ·  Switzerland (1)  ·  Taiwan (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Aijun Chen (1)  ·  Bianca Gutfilen, PhD (1)  ·  Chao Ci (1)  ·  Chao Ji (1)  ·  Chuanjian Lu, PhD (1)  ·  Chunlei Zhang (1)  ·  Chunshui Yu (1)  ·  Denis Poddubnyy, Prof (1)  ·  Fengming Hu (1)  ·  Guoqiang Zhang (1)  ·  Hagar Nofal (1)  ·  Harvey Lui, MD, FRCPC (1)  ·  Hejian Zou, PhD (1)  ·  Hui-Man Cheng (1)  ·  Jia Zhou (1)

Results publications

PMID 21425247, PMID 31930095, PMID 33306625, PMID 34785545, PMID 36189747